Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zymark Corporation was a pioneer and leader in the field of laboratory automation and robotics, specifically tailored for the pharmaceutical and biotechnology industries. Founded in 1981 and headquartered in Hopkinton, Massachusetts, the company developed the first laboratory robot, the Zymate, which revolutionized sample preparation. Its product line expanded to include high-throughput screening systems, liquid handling workstations, and microplate handlers like the Twister. In 2003, Zymark was acquired by Caliper Life Sciences for approximately $60 million, integrating its robotics expertise with Caliper's microfluidics technology. Today, Zymark's legacy continues through the laboratory automation portfolios of Revvity (formerly PerkinElmer).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zymark.